Hatch-Waxman & Biologics

March 23, 2023 Publications

Resistance or Defiance? The FDA and the 11th Circuit Spar Over Statute on Orphan Drug Statutory Exclusivity

Co-Author, Clinical Leader

Chad Landmon, Hatch-Waxman & Biologics Chair, discusses the challenges to the FDA's interpretation of the Orphan Drug Act.

Resources

Read the full article

Firm Highlights

Slide 1 of 6

Event
AI in Action: Modern Approaches to Life Sciences Patent Litigation
Join Polsinelli for this webinar that will explore practical applications of AI for substantive patent analysis and patent litigation workflows, while sharing best practices for using these tools responsibly and effectively.
Read more
News
Polsinelli Wins Deal of the Year at Los Angeles Business Journal’s 2026 M&A Awards
Polsinelli was awarded Deal of the Year in the $500 Million–$1 Billion category at the Los Angeles Business Journal’s second annual M&A Awards for its representation of Astrana Health in its $708 million acquisition of a significant portion of Prospect Health’s medical system.
Read more
Publication
Polsinelli Life Sciences Spotlight - Volume 4 - Built on Strategy: Practical Perspectives Across Life Sciences
Polsinelli’s Life Sciences Spotlight, Volume 4 brings together perspectives from attorneys working across the life sciences ecosystem, with a focus on the issues that can shape strategy today and influence what becomes possible tomorrow.
Read more
Publication
BCBSIL’s New Downcoding Policy Raises Reimbursement Concerns Ahead of New Illinois Restrictions
Blue Cross and Blue Shield of Illinois (BCBSIL) recently implemented changes to its claims-review process that may reduce reimbursement for certain evaluation and management (E/M) services.
Read more
Blog
What Happens When a Customer Harasses an Employee?
Read more
Publication
Immigration and the Health Care Workforce: September 2026 Update
Four recent federal actions are reshaping the cost, timing and risk of hiring foreign-national clinicians and researchers, with implications across recruitment, training, retention and employment transitions.
Read more

Resistance or Defiance? The FDA and the 11th Circuit Spar Over Statute on Orphan Drug Statutory Exclusivity

Resources

Related People

Related Capabilities